| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.44 | 0.008 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |